John M. Leonard

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics Inc, 40 Erie Street, Suite 130, Cambridge, MA
Signature
/s/ Matthew Gilmartin, Attorney-in-Fact for John M. Leonard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John M. Leonard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. President and CEO, Director Common Stock 960K $28.2M $29.38 Mar 1, 2024 Direct
IQVIA HOLDINGS INC. Director Common Stock 13.8K $3.45M $249.97 May 7, 2024 Direct
Intellia Therapeutics, Inc. President and CEO, Director Common Stock 58.4K $1.72M $29.38 Mar 1, 2024 By Trust
Intellia Therapeutics, Inc. President and CEO, Director Restricted Stock Unit 7.85K $188K $23.90 Jan 1, 2024 Direct
Intellia Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 164K Mar 1, 2024 Direct

Insider Reports Filed by John M. Leonard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IQV IQVIA HOLDINGS INC. May 7, 2024 1 $0 4 May 9, 2024 Director
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 1 -$566K 4 Jan 5, 2024 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2024 2 $0 4 Jan 3, 2024 President and CEO, Director
IQV IQVIA HOLDINGS INC. May 10, 2023 1 $0 4 May 12, 2023 Director
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 4, 2023 1 -$248K 4 Jan 6, 2023 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 President and CEO, Director
IQV IQVIA HOLDINGS INC. May 11, 2022 1 $0 4 May 13, 2022 Director
NTLA Intellia Therapeutics, Inc. Jan 1, 2022 5 -$280K 4 Mar 4, 2022 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 30, 2021 21 -$17.4M 4 Sep 1, 2021 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 23, 2021 5 -$3.76M 4 Aug 25, 2021 President and CEO, Director
NTLA Intellia Therapeutics, Inc. Aug 19, 2021 5 -$3.13M 4 Aug 20, 2021 President and CEO, Director